The 1 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 80.00, with a high estimate of 80.00 and a low estimate of 80.00. The median estimate represents a +3,900.00% increase from the last price of 2.00.
The current consensus among 2 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$10.20
Reporting Date Mar 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.